Surgery Partners (SGRY)
(Delayed Data from NSDQ)
$29.83 USD
-0.11 (-0.37%)
Updated Mar 28, 2024 04:00 PM ET
After-Market: $29.79 -0.04 (-0.13%) 7:58 PM ET
3-Hold of 5 3
B Value B Growth F Momentum B VGM
Income Statements
Fiscal Year end for Surgery Partners, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 2,743 | 2,539 | 2,225 | 1,860 | 1,831 |
Cost Of Goods | 2,096 | 1,964 | 1,734 | 1,480 | 1,408 |
Gross Profit | 648 | 575 | 491 | 380 | 424 |
Selling & Adminstrative & Depr. & Amort Expenses | 348 | 255 | 212 | 218 | 208 |
Income After Depreciation & Amortization | 300 | 320 | 280 | 161 | 216 |
Non-Operating Income | 0 | 0 | 0 | 0 | -2 |
Interest Expense | 193 | 235 | 221 | 202 | 179 |
Pretax Income | 135 | 110 | 81 | -19 | 55 |
Income Taxes | 0 | 23 | 11 | -20 | 10 |
Minority Interest | 147 | 142 | 142 | 117 | 120 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 135 | 87 | 71 | 1 | 45 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -12 | -55 | -71 | -116 | -75 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 418 | 435 | 378 | 256 | 292 |
Depreciation & Amortization (Cash Flow) | 118 | 115 | 99 | 95 | 77 |
Income After Depreciation & Amortization | 300 | 320 | 280 | 161 | 216 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 125.61 | 91.95 | 72.43 | 48.78 | 48.28 |
Diluted EPS Before Non-Recurring Items | 0.86 | -0.04 | -0.25 | -1.49 | -1.10 |
Diluted Net EPS (GAAP) | -0.09 | -0.59 | -1.12 | -3.19 | -2.29 |
Fiscal Year end for Surgery Partners, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | 12/31/22 | |
---|---|---|---|---|---|
Sales | 735.40 | 674.10 | 667.60 | 666.20 | 707.10 |
Cost Of Goods | 541.80 | 508.30 | 513.50 | 532.20 | 522.80 |
Gross Profit | 193.60 | 165.80 | 154.10 | 134.00 | 184.30 |
SG&A, R&D, and Dept/Amort Expenses | 101.80 | 90.20 | 61.70 | 94.20 | 98.90 |
Income After SG&A, R&D, and Dept/Amort Expenses | 91.80 | 75.60 | 92.40 | 39.80 | 85.40 |
Non-Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Expense | 48.70 | 49.80 | 47.70 | 46.80 | 61.00 |
Pretax Income | 52.70 | 32.80 | 49.90 | -0.40 | 33.20 |
Income Taxes | 6.00 | 3.10 | -7.80 | -1.60 | 9.90 |
Minority Interest | 47.70 | 34.60 | 38.80 | 26.10 | 46.70 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | 46.70 | 29.70 | 57.70 | 1.20 | 23.30 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | -1.00 | -4.90 | 18.90 | -24.90 | -23.40 |
Earnings Per Share Data | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | 12/31/22 |
---|---|---|---|---|---|
Average Shares | 125.77 | 125.75 | 127.37 | 125.21 | 101.89 |
Diluted EPS Before Non-Recurring Items | 0.40 | 0.15 | 0.25 | 0.05 | 0.22 |
Diluted Net EPS (GAAP) | 0.00 | -0.04 | 0.15 | -0.20 | -0.24 |